Valganciclovir
Back to searchMolecule Structure
Scientific Name
Valganciclovir
Description of the Drug
Valganciclovir is an antiviral medication used to treat cytomegalovirus (CMV) retinitis in patients diagnosed with acquired immunodeficiency syndrome (AIDS).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01610
http://www.drugbank.ca/drugs/DB01610
Brand Name(s)
Not Available
Company Owner(s)
Mylan Pharmaceuticals Inc, Actavis Laboratories Fl Inc, Hetero Labs Ltd Unit V, Ajanta Pharma Ltd, Cipla Ltd, Hoffmann La Roche Inc, Granules Pharmaceuticals Inc, Dr Reddys Laboratories Ltd, Endo Pharmaceuticals Inc, Aurobindo Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human herpesvirus 1 DNA polymerase | SINGLE PROTEIN | INHIBITOR | CHEMBL1872 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL28996 | SCHEMBL22357189 | |||
| PharmGKB | PA10227 | ||||
| Human Metabolome Database | HMDB0015548 | ||||
| WDI | DR9802079 | ||||
| DrugBank | DB01610 | ||||
| PubChem: Thomson Pharma | 15916891 | 16867892 | 14852135 | 16292870 | 14852136 |
| PubChem | 135413535 | ||||
| Nikkaji | J1.170.632K | ||||
| EPA CompTox Dashboard | DTXSID8048288 | ||||
| DrugCentral | 2801 | ||||
| Brenda | 208586 | 72233 | 208587 | ||
| Guide to Pharmacology | 4716 | ||||
| rxnorm | VALGANCICLOVIR HYDROCHLORIDE | VALCYTE | VALGANCICLOVIR | ||
| ChEBI | 63635 |
